4

OWNERSHIP DOCUMENT

Company: Protalix BioTherapeutics, Inc.
Filed: September 18, 2014
Period of Report: September 16, 2014
Accession Number: 0001178913-14-002976

View Document ↗ View on SEC.gov ↗